Pacific Biosciences of California, Inc.(PACB) stock price and fundamentals

Medical - Devices · Menlo Park, CA

$2.70-0.17 (-5.92%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instruments are essential consumable products, such as their unique single molecule real-time (SMRT) cells. Furthermore, the company supplies a comprehensive suite of workflow-specific reagent kits. These include template preparation kits, which utilize molecular biology reagents (like ligase, buffers, and exonucleases) to convert DNA into SMRTbell double-stranded DNA libraries. Binding kits, featuring modified DNA polymerase, facilitate the crucial attachment of SMRTbell libraries to the polymerase in readiness for sequencing. Finally, specialized sequencing kits contain all necessary reagents, including phospholinked nucleotides, for real-time sequencing directly on their instruments. Pacific Biosciences caters to a broad global clientele, encompassing prominent research institutions, commercial diagnostic laboratories, large-scale genome centers, public health organizations, hospitals, clinical research institutes, contract research organizations (CROs), academic bodies, pharmaceutical firms, and agricultural enterprises. Product commercialization is managed through a direct sales force across North America and Europe, complemented by a robust network of distribution partners spanning Asia, the Middle East, Africa, and Latin America. A significant strategic alliance includes a development and commercialization agreement with Invitae Corporation. Originally incorporated in 2000 as Nanofluidics, Inc., the company adopted its current name, Pacific Biosciences of California, Inc., in 2005. Its corporate headquarters are situated in Menlo Park, California.

Menlo Park, CA

485 employees

www.pacb.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Mark Van Oene

View full financials

Stock	Market Cap	Close Price	Price Change	TTM Total Return	5Y CAGR	10Y CAGR	Compare
1PACB	$838.62M	$2.70	-5.92%	+92.02%	-35.20%	-10.80%	N/A
2BBNX	$838.16M	$18.63	-1.69%	-14.80%	N/A	N/A	vs PACB
3GLUE	$833.81M	$9.87	-3.89%	+32.51%	-12.32%	N/A	vs PACB
4SGP	$828.48M	$24.78	-3.17%	N/A	N/A	N/A	vs PACB
5SLBT	$852.35M	$1.52	-4.40%	N/A	N/A	N/A	vs PACB
6RIGL	$853.13M	$46.11	-3.52%	+67.04%	+6.25%	+1.77%	vs PACB

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$-0.14	$-0.13	$-0.12	4
Quarter ending Dec 2026	$-0.14	$-0.13	$-0.12	4
Quarter ending Mar 2027	$-0.13	$-0.12	$-0.11	1
Quarter ending Jun 2027	$-0.13	$-0.12	$-0.11	1

Period	Low	Avg	High	# Analysts
FY 2026	$-0.49	$-0.46	$-0.43	4
FY 2027	$-0.49	$-0.46	$-0.43	4

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$38.77M	$39.33M	$39.89M	4
Quarter ending Dec 2026	$40.93M	$43.24M	$45.56M	4
Quarter ending Mar 2027	$39.75M	$42.51M	$44.55M	2
Quarter ending Jun 2027	$41.22M	$44.07M	$46.19M	2

FY 2026	$155.88M	$158.73M	$161.57M	4
FY 2027	$178.13M	$182.43M	$186.74M	5

Pacific Biosciences of California, Inc.(PACB) stock price and fundamentals

Valuation

PACB Price Chart

Business at a glance

PACB Key Metrics

Total Return CAGR

PACB Fundamental Charts

Revenue CAGR

PACB Selected Revenue Disclosures

Product / business disclosures (FY 2025)

PACB Earnings Preview

Similar-Size Sector Stocks

PACB Competitors' Key Metrics

PACB Charts

Valuation Charts

Performance Charts

Dividend Charts

CAGR Charts

Financial Statement Charts

Other Charts

Geographic disclosures (FY 2025)

PACB Analyst Ratings

PACB Analyst Estimates

Earnings Per Share (EPS) Estimates

Revenue Estimates